ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 341,29
-0,19%
Dow Jones
42 992,21
-0,77%
DAX
19 936,10
-0,11%
Brent Oil
73,74
0,16%
Bitcoin
93 720,03
0,21%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Opko Health Inc (OPK)

  7. Opko Health Inc (OPK) Actualités

OPK

Opko Health (OPK)

Opko Health Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OPK
DateHeureSourceTitreSymboleSociété
10/12/202414h00PR Newswire (US)NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerNASDAQ:OPKOpko Health Inc
21/11/202403h36Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
20/11/202414h00GlobeNewswire Inc.OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPKOpko Health Inc
18/11/202414h00PR Newswire (US)NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNASDAQ:OPKOpko Health Inc
14/11/202412h00PR Newswire (US)NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 ResultsNASDAQ:OPKOpko Health Inc
13/11/202422h30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:OPKOpko Health Inc
08/11/202422h05GlobeNewswire Inc.Entera Bio Reports Q3 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
07/11/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
07/11/202422h05GlobeNewswire Inc.OPKO Health Reports Third Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
07/11/202414h00GlobeNewswire Inc.Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®NASDAQ:OPKOpko Health Inc
29/10/202421h05GlobeNewswire Inc.OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:OPKOpko Health Inc
07/10/202414h00PR Newswire (US)NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into JapanNASDAQ:OPKOpko Health Inc
07/10/202414h00GlobeNewswire Inc.ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramNASDAQ:OPKOpko Health Inc
25/09/202414h30GlobeNewswire Inc.Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic DisordersNASDAQ:OPKOpko Health Inc
23/09/202414h00GlobeNewswire Inc.OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical DevelopmentNASDAQ:OPKOpko Health Inc
20/09/202420h56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPKOpko Health Inc
16/09/202413h30PR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNASDAQ:OPKOpko Health Inc
30/08/202423h01Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:OPKOpko Health Inc
19/08/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
09/08/202422h05GlobeNewswire Inc.Entera Bio Reports Q2 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
07/08/202422h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
07/08/202422h06GlobeNewswire Inc.OPKO Health Reports Second Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
01/08/202422h05GlobeNewswire Inc.OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:OPKOpko Health Inc
18/07/202414h00GlobeNewswire Inc.OPKO Health Announces $100 Million Share Repurchase ProgramNASDAQ:OPKOpko Health Inc
17/07/202422h14GlobeNewswire Inc.OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share PaymentsNASDAQ:OPKOpko Health Inc
02/07/202414h00PR Newswire (US)NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing PartnerNASDAQ:OPKOpko Health Inc
31/05/202416h48GlobeNewswire Inc.OPKO Health to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OPKOpko Health Inc
07/05/202422h05GlobeNewswire Inc.OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
03/05/202414h00GlobeNewswire Inc.OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:OPKOpko Health Inc
28/03/202413h00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNASDAQ:OPKOpko Health Inc
 Showing the most relevant articles for your search:NASDAQ:OPK

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
EU
AI
Air Liquide
EU
VK
Vallourec
EU
CAP
Capgemini
EU
ACA
Credit Agricole
EU
CS
Axa
EU
BNP
BNP Paribas
EU
BEL20
Bel 20
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
COIN
BTCUSD
Bitcoin
COIN
ADAUSD
Cardano
EU
EN
Bouygues
SPI
SP500
S&P 500
COIN
AVAXUSD
Avalanche
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés